Dutasteride CAS 164656-23-9
Dual 5α-Reductase Inhibitor (DHT Blocker)
Dutasteride (CAS 164656-23-9) is a synthetic 4-azasteroid that inhibits both type I and type II steroid 5α-reductase isozymes. By blocking conversion of testosterone to dihydrotestosterone (DHT) at both isozymes, it suppresses DHT more completely than selective type II inhibitors, and is a key research compound for androgenetic alopecia and benign prostatic hyperplasia (BPH). Formula C27H30F6N2O2, MW 528.53. Research / pharma grade with COA.
Molecular Information
CAS: 164656-23-9
Formula: C27H30F6N2O2
MW: 528.53 g/mol
Class: 4-Azasteroid dual 5α-reductase inhibitor
Core: 4-Aza-5α-androst-1-ene-17β-carboxamide
Target: 5α-reductase (type I & II)
Activity: DHT suppression (broad)
MP: Reported ~242-250 °C
Appearance: White to off-white powder
Synonyms: GG-745; Avodart
Storage: -20°C, protect from light
Product Technical Specifications
Complete physicochemical properties and QC parameters for Dutasteride (CAS 164656-23-9)
📋 Physicochemical Properties
- Product NameDutasteride
- IUPAC Name(5α,17β)-N-[2,5-bis(trifluoromethyl)phenyl]-3-oxo-4-azaandrost-1-ene-17-carboxamide
- CAS Number164656-23-9
- SynonymsGG-745; Avodart
- Molecular FormulaC27H30F6N2O2
- Molecular Weight528.53 g/mol
- SourceSynthetic 4-azasteroid
- AppearanceWhite to off-white powder
- Water SolubilityPractically insoluble
- Organic SolubilityDMSO; ethanol; methanol; PEG-400
- Melting Point~242-250 °C
- Compound ClassDual 5α-reductase inhibitor (anti-androgen)
- HS Code2937.29
🔬 Quality Control & Handling
- Purity (HPLC)≥98%
- FormCrystalline powder
- Primary Target5α-reductase (type I & II)
- Assay ReadoutDHT / androgen readouts
- SelectivityDual type I + II 5α-reductase
- Storage Condition-20°C, sealed, protect from light
- Solution StabilityDMSO stock stable at -20°C
- ShippingRoom temp / cold chain
- QC DocumentationCOA / HPLC / NMR / MS / MSDS
- Pack Sizes100mg / 500mg / 1g / 5g / 10g
- Stock StatusIn Stock
- Use StatementResearch / formulation use; not for human clinical use
Key Molecular Targets & Pathway Nodes
Dutasteride engages both 5α-reductase isozymes at the core of androgen-driven hair loss and prostatic research.
How Dutasteride Works: Broad-Spectrum DHT Suppression
Dutasteride blocks both 5α-reductase isozymes, giving more complete DHT lowering than type II-selective agents.
Dual Inhibition of 5α-Reductase
Dutasteride inhibits both type I and type II steroid 5α-reductase, the enzymes that convert testosterone into the potent androgen dihydrotestosterone (DHT).
Near-Complete DHT Reduction
Because both isozymes are blocked, scalp and serum DHT fall more completely than with type II-selective inhibitors, weakening androgenic signaling throughout target tissues.
Follicular & Prostatic Response
Profound DHT lowering reduces hair-follicle miniaturization (alopecia models) and prostatic androgenic stimulation (BPH models), supporting healthier phenotypes.
⚖️ Dutasteride vs Comparators
- Dutasteride (this product)Dual type I + II 5α-reductase inhibitor
- FinasterideSelective type II 5α-reductase inhibitor
- MinoxidilK⁺-channel vasodilator (topical)
- Selective EdgeBroader, more complete DHT suppression
- Research NicheHair loss & BPH / androgen studies
♻️ Downstream Biological Consequences
- Enzyme5α-reductase (I+II) blocked
- AndrogenDHT markedly reduced
- FollicleMiniaturization reversed
- ScalpHair density readouts up
- ProstateAndrogenic volume down (BPH)
- ModelsAndrogen / alopecia pharmacology
Research & Formulation Applications
Dutasteride is a high-potency anti-androgen for hair-loss, prostatic and endocrinology research.
Androgenetic Alopecia Research
High-potency comparator for DHT-driven follicle-miniaturization models.
Hair LossBPH Models
Prostatic androgenic-stimulation and volume studies.
BPHDual 5α-Reductase Profiling
Benchmarks type I + II isozyme inhibition and steroid SAR.
5α-RAndrogen Pathway Studies
DHT, testosterone and AR-signaling assays.
AndrogenHead-to-Head vs Finasteride
Comparative DHT-lowering and efficacy studies.
ComparatorEndocrinology Research
Steroid-metabolism and anti-androgen pharmacology.
EndoKey Literature & Landmark Publications
Landmark clinical and preclinical work on dutasteride, dual 5α-reductase inhibition and androgenetic alopecia.
Available Sizes & Ordering
Research / pharma-grade Dutasteride (CAS 164656-23-9) with full QC documentation; standard packs and bulk custom quantities supported.
| Tier | Pack Size | Stock Status | Suitable For | Lead Time |
|---|---|---|---|---|
| Standard | 100 mg | In Stock | Receptor / DHT assays | Same/next-day ship |
| Medium | 500 mg | In Stock | Cell & binding studies | Same/next-day ship |
| Large | 1 g | In Stock | In vivo models | Same/next-day ship |
| Bulk | 5 g | In Stock | Screening & formulation | Quote to confirm |
| Industrial | 10 g+ | Made to order | Process development | Batch delivery |
💡 Reference sizes shown above; for exact pricing and availability please contact us for a quote. Bulk orders qualify for tiered discounts.
Frequently Asked Questions (FAQ)
What is dutasteride and what is it researched for?
How does dutasteride work?
What is the difference between dutasteride and finasteride?
How soluble is dutasteride and how should it be prepared?
Is dutasteride a hormonal compound?
Is QC documentation provided?
Need Dutasteride for Your Research?
Research / pharma-grade Dutasteride (CAS 164656-23-9) — purity ≥98% HPLC, COA included
Dual (I+II) 5α-reductase inhibitor (DHT blocker) — request a quote today




